MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12885-025-14963-7

Медицинская библиотека · BMC cancer · 2025

Unveiling GDF15 as a promising biomarker for predicting survival in pancreatic ductal carcinoma: a retrospective research.

Xiao Jianchun, Lu Xiaoyue, Luo Wenhao, Wang Yicheng, Zhang Taiping

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The prognosis of pancreatic ductal adenocarcinoma remains dismal, largely because this disease is typically diagnosed at an advanced stage, making early detection a major challenge. Beyond the conventional biomarker CA19-9, emerging evidence suggests the utility of additional markers for distinguishing PDAC from normal pancreatic tissue or chronic pancreatitis. Among these, Growth Differentiation Factor 15 (GDF15), implicated in various malignancies, has arisen as a promising candidate, particularly when expressed at elevated levels in pancreatic cancer. Recent insights into the oncogenic potential of GDF15 underscore its prognostic significance.

METHODS

In this study, a comprehensive analysis was performed by integrating clinicopathological data with GDF15 expression profiles from a retrospective clinical cohort. Immunohistochemical staining was used to quantify GDF15 expression in tissue samples, and expression levels were stratified using a prognosis-oriented threshold. Kaplan-Meier survival analysis was conducted to evaluate its association with overall survival.

RESULTS

GDF15 was found to be markedly overexpressed in PDAC tissues relative to adjacent normal pancreas, supporting its potential role in promoting tumor development. In addition, high GDF15 levels were significantly linked to unfavorable clinical outcomes, underscoring its value as a prognostic indicator in pancreatic cancer.

CONCLUSIONS

The findings contribute novel insights into the role of GDF15, reinforcing its potential as a valuable prognostic biomarker for pancreatic cancer.

Для цитирования: Xiao Jianchun, Lu Xiaoyue, Luo Wenhao, Wang Yicheng, Zhang Taiping. Unveiling GDF15 as a promising biomarker for predicting survival in pancreatic ductal carcinoma: a retrospective research.. BMC cancer. 2025. DOI: 10.1186/s12885-025-14963-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.